Trial Outcomes & Findings for Supporting Our Caregivers In ADRD Learning (SOCIAL) (NCT NCT06276023)
NCT ID: NCT06276023
Last Updated: 2026-09-02
Results Overview
The proportion of eligible participants who are eligible and choose to enroll in the study and the percentage of racial and ethnically diverse participants enrolled.
COMPLETED
NA
82 participants
Baseline
2026-09-02
Participant Flow
82 participants provided informed consent and were enrolled in the study. 14 enrolled participants did not proceed to intervention assignment/start due to withdrawal, loss to follow-up prior to intervention/randomization. Therefore, 68 participants were randomized and started the intervention.
Participant milestones
| Measure |
Mindful and Self-Compassionate Care Program (MASC)
The intervention arm will be comprised of:
Six Virtual Group Sessions. The sessions will teach mindfulness, self-compassion and behavioral management skills.
At Home Practice. After each group session, participants will have the opportunity to integrate the practices learned into their everyday life.
Mindful and Self-Compassionate Care Program (MASC): The intervention arm will be comprised of:
Six Virtual Group Sessions. The sessions will teach mindfulness, self-compassion and behavioral management skills.
At Home Practice. After each group session, participants will have the opportunity to integrate the practices learned into their everyday life.
|
Health Education Program (HEP)
The control arm will be comprised of:
Six Virtual Group Sessions. The sessions will discuss caregiver stress, sleep hygiene, nutrition, and ways to stay physically active as a caregiver.
At Home Practice. After each group session, participants will have the opportunity to complete journal exercises that encourage them to integrate the health information that they learn into their daily lives.
Health Education Program (HEP): The control arm will be comprised of:
Six Virtual Group Sessions. The sessions will discuss caregiver stress, sleep hygiene, nutrition, and ways to stay physically active as a caregiver.
At Home Practice. After each group session, participants will have the opportunity to complete journal exercises that encourage them to integrate the health information that they learn into their daily lives.
|
|---|---|---|
|
Overall Study
STARTED
|
45
|
23
|
|
Overall Study
COMPLETED
|
44
|
23
|
|
Overall Study
NOT COMPLETED
|
1
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Supporting Our Caregivers In ADRD Learning (SOCIAL)
Baseline characteristics by cohort
| Measure |
Mindful and Self-Compassionate Care Program (MASC)
n=45 Participants
The intervention arm will be comprised of:
Six Virtual Group Sessions. The sessions will teach mindfulness, self-compassion and behavioral management skills.
At Home Practice. After each group session, participants will have the opportunity to integrate the practices learned into their everyday life.
Mindful and Self-Compassionate Care Program (MASC): The intervention arm will be comprised of:
Six Virtual Group Sessions. The sessions will teach mindfulness, self-compassion and behavioral management skills.
At Home Practice. After each group session, participants will have the opportunity to integrate the practices learned into their everyday life.
|
Health Education Program (HEP)
n=23 Participants
The control arm will be comprised of:
Six Virtual Group Sessions. The sessions will discuss caregiver stress, sleep hygiene, nutrition, and ways to stay physically active as a caregiver.
At Home Practice. After each group session, participants will have the opportunity to complete journal exercises that encourage them to integrate the health information that they learn into their daily lives.
Health Education Program (HEP): The control arm will be comprised of:
Six Virtual Group Sessions. The sessions will discuss caregiver stress, sleep hygiene, nutrition, and ways to stay physically active as a caregiver.
At Home Practice. After each group session, participants will have the opportunity to complete journal exercises that encourage them to integrate the health information that they learn into their daily lives.
|
Total
n=68 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=136 Participants
|
0 Participants
n=136 Participants
|
0 Participants
n=272 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
29 Participants
n=136 Participants
|
13 Participants
n=136 Participants
|
42 Participants
n=272 Participants
|
|
Age, Categorical
>=65 years
|
16 Participants
n=136 Participants
|
10 Participants
n=136 Participants
|
26 Participants
n=272 Participants
|
|
Age, Continuous
|
57.44 years
STANDARD_DEVIATION 12.53 • n=136 Participants
|
60.26 years
STANDARD_DEVIATION 14.06 • n=136 Participants
|
58.40 years
STANDARD_DEVIATION 13.03 • n=272 Participants
|
|
Sex: Female, Male
Female
|
38 Participants
n=136 Participants
|
19 Participants
n=136 Participants
|
57 Participants
n=272 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=136 Participants
|
4 Participants
n=136 Participants
|
11 Participants
n=272 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
2 Participants
n=136 Participants
|
0 Participants
n=136 Participants
|
2 Participants
n=272 Participants
|
|
Race (NIH/OMB)
Asian
|
1 Participants
n=136 Participants
|
2 Participants
n=136 Participants
|
3 Participants
n=272 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=136 Participants
|
0 Participants
n=136 Participants
|
0 Participants
n=272 Participants
|
|
Race (NIH/OMB)
Black or African American
|
5 Participants
n=136 Participants
|
2 Participants
n=136 Participants
|
7 Participants
n=272 Participants
|
|
Race (NIH/OMB)
White
|
34 Participants
n=136 Participants
|
19 Participants
n=136 Participants
|
53 Participants
n=272 Participants
|
|
Race (NIH/OMB)
More than one race
|
1 Participants
n=136 Participants
|
0 Participants
n=136 Participants
|
1 Participants
n=272 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
2 Participants
n=136 Participants
|
0 Participants
n=136 Participants
|
2 Participants
n=272 Participants
|
|
Region of Enrollment
United States
|
45 participants
n=136 Participants
|
23 participants
n=136 Participants
|
68 participants
n=272 Participants
|
PRIMARY outcome
Timeframe: BaselinePopulation: 119 participants were eligible and 82 chose to enroll.
The proportion of eligible participants who are eligible and choose to enroll in the study and the percentage of racial and ethnically diverse participants enrolled.
Outcome measures
| Measure |
Control
HEP
|
Intervention
n=119 Participants
MASC
|
|---|---|---|
|
Feasibility of Recruitment
Enrolled Participants
|
—
|
82 Participants
|
|
Feasibility of Recruitment
Racial and Ethnic Minorities
|
—
|
36 Participants
|
PRIMARY outcome
Timeframe: Baseline, Post intervention (6-8 weeks post baseline)Population: In the intervention group, 1 participant did not complete the post-test.
The percentage randomized who complete the post-test.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Feasibility of Randomization
|
23 Participants
|
44 Participants
|
PRIMARY outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention arm, 4 participants did not complete the study with less than 25% of missing questionnaires in the post-test, and 5 participants did not complete the study with less than 25% of missing questionnaires in the 3-month follow-up. In the control arm, 1 participant did not complete the study with less than 25% of missing questionnaires in the post-test, and 4 participants did not complete the study with less than 25% of missing questionnaires in the 3-month follow-up
The proportion of participants who completed the study and had fewer than 25% of all expected study questionnaires missing across the entire assessment period. This participant-level measure assessed overall study completion and questionnaire adherence.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Feasibility of Assessment Measures
Post-test
|
22 Participants
|
41 Participants
|
|
Feasibility of Assessment Measures
3 month follow-up
|
19 Participants
|
40 Participants
|
|
Feasibility of Assessment Measures
Baseline
|
23 Participants
|
45 Participants
|
PRIMARY outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention arm, 4 participants had questionairres missing in the post-test, and 5 participants had questionairres missing in the 3-month follow-up. In the control arm, 1 participant had questionairres missing in the post-test, and 4 participants had questionairres missing in the 3-month follow-up.
Assessing whether at least 75% of participants completed every study question in the questionnaire (of note: no questionnaire in this study was entirely missing). The benchmark was met if no more than 25% of participants had one or more questionnaires that were completely missing.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Feasibility of Quantitative Measures
Baseline
|
23 Participants
|
45 Participants
|
|
Feasibility of Quantitative Measures
Post-test
|
22 Participants
|
41 Participants
|
|
Feasibility of Quantitative Measures
3 month follow-up
|
19 Participants
|
40 Participants
|
PRIMARY outcome
Timeframe: Post-intervention (Up to 8 weeks post baseline)The proportion of caregivers who attend at least 4 out of the 6 sessions out of all randomized caregivers. Adherence to treatment will be estimated for both HEP and MASC.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Adherence to Treatment
|
22 Participants
|
42 Participants
|
PRIMARY outcome
Timeframe: Post-intervention (6-8 weeks post baseline)Population: Data not collected; The outcome was prespecified but was inadvertently omitted from the final case report form/data collection instrument.
PGIC is a 7-point scale depicting a participant's rating of overall improvement. Participants rate their change as "very much improved", "much improved", "minimally improved", "no change", "minimally worse", "much worse" or "very much worse"
Outcome measures
| Measure |
Control
HEP
|
Intervention
MASC
|
|---|---|---|
|
Patient's Global Impression of Change (PGIC)
|
0 Participants
|
0 Participants
|
PRIMARY outcome
Timeframe: Post-intervention (6-8 weeks post baseline)Population: In the intervention arm, 2 participants did not note their post-test stress (they completed other sections of the post-intervention form, and therefore still were analyzed, this instrument specifically is missing).
The 'Perceptions of Questionnaire Battery' qualitative measure assesses how appropriately the participants fill the questionnaires, address their perception of stress, emotional distress and all other questionnaires.
Outcome measures
| Measure |
Control
n=22 Participants
HEP
|
Intervention
n=43 Participants
MASC
|
|---|---|---|
|
Perceptions of Questionnaire Battery
Missingness (No questionnaires missing fully in post-test)
|
22 Participants
|
41 Participants
|
|
Perceptions of Questionnaire Battery
Number of participants who do not note their post-test stress
|
0 Participants
|
2 Participants
|
PRIMARY outcome
Timeframe: Weekly (up to 6 weeksThe proportion of participants who complete more than 50% weekly home practice.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Adherence to Home Practice
Completed more than 50%
|
15 Participants
|
28 Participants
|
|
Adherence to Home Practice
Completed less than 50%
|
8 Participants
|
17 Participants
|
PRIMARY outcome
Timeframe: Post-intervention (6-8 weeks post baseline)Population: In intervention group, 3 participant answers are missing. In the control group,1 participant answer is missing. Text reminders ended up not be utilized, so that answer is N/A.
Participants' perception of emails and text messages reminders. The single question -, "Do participants think that the number of emails/texts received was: too little, just enough, too much?"
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=44 Participants
MASC
|
|---|---|---|
|
Perceptions of Email and Text Reminders
Too much
|
3 Participants
|
3 Participants
|
|
Perceptions of Email and Text Reminders
Missing
|
1 Participants
|
3 Participants
|
|
Perceptions of Email and Text Reminders
Too little
|
1 Participants
|
3 Participants
|
|
Perceptions of Email and Text Reminders
Just enough
|
18 Participants
|
35 Participants
|
PRIMARY outcome
Timeframe: BaselinePopulation: In the intervention group, 42 participants answered the baseline questions about credibility, and 44 answered the baseline questions about expectancy. In the control group, 21 participants answered the baseline questions about credibility, and 22 answered the baseline questions about expectancy.
The Credibility and Expectancy Questionnaire (CEQ) assesses participants' perceptions that the treatment will work after participating in the intervention. It consists of 6 items divided into two subscales, with scoring is based on dividing the items into Credibility and Expectancy. Items 1-3: Assess Treatment Credibility, scored on a 1 to 9 scale (where 1 represents "not at all" and 9 represents "very much"; the subscale score is the sum of these three items, range: 3-27; a higher score indicates a better outcome). Items 4-6: Assess Treatment Expectancy, scored on a 0% to 100% scale (values are recoded to match the 1 to 9 scale of the previous items; once recoded, values range from 3-27; higher scores represent a better outcome). Credibility Score: Calculate the sum (or average) of items 1-3; a higher score indicates a better outcome. Expectancy Score: Calculate the sum (or average) of items 4-6; a higher score indicates a better outcome.
Outcome measures
| Measure |
Control
n=22 Participants
HEP
|
Intervention
n=44 Participants
MASC
|
|---|---|---|
|
Credibility and Expectancy
Credibility
|
23.19 score on a scale
Standard Deviation 2.80
|
22.31 score on a scale
Standard Deviation 4.05
|
|
Credibility and Expectancy
Expectancy
|
16.86 score on a scale
Standard Deviation 4.62
|
16.96 score on a scale
Standard Deviation 4.70
|
PRIMARY outcome
Timeframe: (6-8 weeks post baseline)Population: In the intervention group, 41 participants answered MPGI questions. In the control group, 22 participants answered MPGI questions.
The Modified Perception of Global Improvement (MPGI) is a global index designed to measure a participant's interpretation of changes in perceptions of stress following intervention. The MPGI uses a 7-point Likert scale, with 1 = Very Much Improved and 7 = Very Much Worse (lower score represents a better outcome). For the data below, the scores were converted as follows: Improved - original scores of 1-3 converted to a zero Not improved - original score 4-7 converted to a 1. The averages of the converted scores were computed, with a score ranging from 0-1 (with a lower score representing a better outcome).
Outcome measures
| Measure |
Control
n=22 Participants
HEP
|
Intervention
n=41 Participants
MASC
|
|---|---|---|
|
Modified Perception of Global Improvement
|
0.55 score on a scale
Standard Deviation 0.51
|
0.80 score on a scale
Standard Deviation 0.40
|
PRIMARY outcome
Timeframe: Post-intervention (6-8 weeks post baseline)Population: In the intervention group, 40 participants answered CSQ questions. In the control group, 22 participants answered CSQ questions.
The investigators will use the Client Satisfaction Questionnaire (CSQ-3) to assess participants' satisfaction with the intervention. Each of the three questions is scored on a 4-point Likert scale ranging from 1 to 4, where higher numbers indicate greater satisfaction. To calculate the score, you add up the responses from the three questions. Total Score Range: 3 to 12 (higher score represents better outcome).
Outcome measures
| Measure |
Control
n=22 Participants
HEP
|
Intervention
n=40 Participants
MASC
|
|---|---|---|
|
Satisfaction With the Intervention
|
9.50 score on a scale
Standard Deviation 1.60
|
10.23 score on a scale
Standard Deviation 1.65
|
PRIMARY outcome
Timeframe: Baseline through Post-intervention (6-8 weeks post baseline)Ability of therapist to deliver the content of each session (through therapist completed adherence checklists) and therapist fidelity (through independent review of recorded sessions by Co-Investigator). To measure this outcome, recorded sessions were analyzed.
Outcome measures
| Measure |
Control
n=6 Sessions
HEP
|
Intervention
n=16 Sessions
MASC
|
|---|---|---|
|
Therapist Fidelity
Sessions with >= 75% fidelity
|
4 Sessions
|
13 Sessions
|
|
Therapist Fidelity
Sessions with >75% fidelity
|
2 Sessions
|
3 Sessions
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention group, 45 participants answered CES-D questions at baseline. At the post-test, 43 participants answered the CES-D questions. At the follow-up, 41 answered the CES-D questions. In the control group, 23 participants answered CES-D questions at both baseline and post-test. 21 answered the CES-D questions at the follow-up.
Center for Epidemiological Studies-Depression Scale (CES-D). The CES-D is a 20-item scale widely used with Alzheimer's Disease and Related Dementias (ADRD) participants. Response options range from 0 to 3 for each item (0 = Rarely or None of the Time, 1 = Some or Little of the Time, 2 = Moderately or Much of the time, 3 = Most or Almost All the Time) In scoring the CES-D, possible range of scores is 0 to 60, with the higher scores indicating the presence of more symptomatology.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Symptoms of Depression
Baseline
|
20.04 score on a scale
Standard Deviation 11.10
|
25.16 score on a scale
Standard Deviation 10.72
|
|
Symptoms of Depression
Post-test
|
18.26 score on a scale
Standard Deviation 10.04
|
18.33 score on a scale
Standard Deviation 11.19
|
|
Symptoms of Depression
3-months post intervention
|
18.61 score on a scale
Standard Deviation 10.57
|
18.44 score on a scale
Standard Deviation 12.12
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention group, 45 participants answered AMPS questions at baseline. At the post-test, 41 participants answered the AMPS questions. At the 3-month follow-up, 40 answered the AMPS questions. In the control group, 23 participants answered AMPS questions at baseline. At the post-test, 22 participants answered the AMPS questions. At the 3-month follow-up, 19 answered the AMPS questions.
The Applied Mindfulness Process Scale (AMPS) is a process measure used to quantify how participants in mindfulness-based interventions (MBIs) use mindfulness practice when facing challenges in daily life. The AMPS yields 15 items representing three domains of applied mindfulness processes: (a) decentering, (b) positive emotional regulation, and (c) negative emotional regulation. AMPS is scored by adding all 15 items to obtain a score ranging from 0-60, with higher scores indicating higher use of mindfulness.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Mindfulness
Post-test
|
33.45 score on a scale
Standard Deviation 10.27
|
34.66 score on a scale
Standard Deviation 10.20
|
|
Mindfulness
Baseline
|
27.96 score on a scale
Standard Deviation 10.15
|
26.58 score on a scale
Standard Deviation 10.17
|
|
Mindfulness
3-months post intervention
|
34.32 score on a scale
Standard Deviation 11.54
|
35.60 score on a scale
Standard Deviation 12.79
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention group, 45 participants answered PSS questions at baseline. At the post-test, 43 participants answered the PSS questions.In the 3-month follow-up, 41 answered the PSS questions. In the control group, 23 participants answered PSS questions at both baseline and post-test. In the 3-month follow-up, 21 answered the PSS questions.
The Perceived Stress Scale 10 (PSS-10) assesses perceived stress using a 5-point Likert scale. The total score is determined by adding together the scores of each of the four items. Questions 2 and 3 are reverse coded. Questions 1 and 4: 0 = Never; 1 = Almost never; 2 = Sometimes; 3 = Fairly often; 4 = Very often Questions 2 and 3: 4 = Never; 3 = Almost never; 2 = Sometimes; 1 = Fairly often; 0 = Very often. Scores range from 0 to 40 with higher scores indicating more stress.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Perceived Stress Scale
Baseline
|
21.43 score on a scale
Standard Deviation 4.81
|
24.00 score on a scale
Standard Deviation 5.39
|
|
Perceived Stress Scale
Post-test
|
18.70 score on a scale
Standard Deviation 7.36
|
19.60 score on a scale
Standard Deviation 6.74
|
|
Perceived Stress Scale
3-months post intervention
|
19.95 score on a scale
Standard Deviation 5.69
|
19.24 score on a scale
Standard Deviation 6.47
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention group, 45 participants answered STAI questions at baseline. At the post-test, 43 participants answered the STAI questions. At the 3-month follow-up, 41 participants answered the STAI questions. In the control group, 23 participants answered STAI questions at both baseline and post-test. At the 3-month follow-up, 21 participants answered the STAI questions.
The State Trait Anxiety Inventory (STAI) state subscales (20 items) assesses anxiety symptoms in response to stressful situations. The range of possible scores varies from a minimum score of 20 to a maximum score of 80. STAI scores are commonly classified as "no or low anxiety" (20-37), "moderate anxiety" (38-44), and "high anxiety" (45-80).
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Symptoms of Anxiety
3-months post intervention
|
43.62 score on a scale
Standard Deviation 8.89
|
44.02 score on a scale
Standard Deviation 11.51
|
|
Symptoms of Anxiety
Baseline
|
47.78 score on a scale
Standard Deviation 7.29
|
49.76 score on a scale
Standard Deviation 10.19
|
|
Symptoms of Anxiety
Post-Test
|
44.13 score on a scale
Standard Deviation 8.75
|
44.70 score on a scale
Standard Deviation 11.31
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention group, 45 participants answered SCS questions at baseline. At the post-test, 42 participants answered the SCS questions. At the 3-month follow-up, 40 participants answered the SCS questions. In the control group, 23 participants answered SCS questions at baseline. At the post-test, 22 participants answered the SCS questions. At the 3-month follow-up, 19 participants answered the SCS questions.
The Self-Compassion Scale - Short Form (SCS-SF) is a 12-item self-report measure that is used by adults to measure their capacity for self-compassion - the ability to hold one's feelings of suffering with a sense of warmth, connection and concern. All 12 items are scored using a 5-point Likert scale. Before calculating the final score, the following items are reverse-scored so that higher totals always reflect greater self-compassion: negative items that measure harsh self-criticism, isolation, and over-identification (Items 1, 4, 8, 9, 11, 12). Higher scores here indicate a more critical and reactive stance under stress. Positive items that measure self-kindness, common humanity, and mindfulness (Items 2, 3, 5, 6, 7, 10) are left untouched; higher scores mean a warmer, more accepting stance. The finalized 12 scored are summed (the reverse-scored numbers plus the untouched numbers) and divided by 12, for an average overall score between 1.0 and 5.0 with 5 indicating higher SC.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
The Self-Compassion Scale
Baseline
|
3.07 score on a scale
Standard Deviation 0.74
|
2.79 score on a scale
Standard Deviation 0.67
|
|
The Self-Compassion Scale
Post-test
|
3.26 score on a scale
Standard Deviation 0.75
|
3.04 score on a scale
Standard Deviation 0.75
|
|
The Self-Compassion Scale
3-months post intervention
|
3.35 score on a scale
Standard Deviation 0.82
|
2.90 score on a scale
Standard Deviation 1.22
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention group, 45 participants answered CS questions at baseline. At the post-test, 42 participants answered the CS questions. At the 3-month follow-up, 40 participants answered the CS questions. In the control group, 23 participants answered CS questions at baseline. At the post-test, 22 participants answered the CS questions. At the 3-month follow-up, 19 participants answered the CS questions.
The Compassion Scale (CS) has 16 items assessing common humanity, kindness toward others and ability to understand the suffering or challenges of others, all items scored using a 5 point Likert scale. The items are grouped into 4 categories: Kindness (Items 2, 6, 10, 14), Common Humanity (Items 4, 8, 12, 16), Mindfulness (Items 1, 5, 9, 13), Indifference (Items 3, 7, 11, 15). Indifference items are reverse scored so that a higher number corresponds to higher compassion. The mean of each subscale is calculated. The, using the reverse-coded indifference scores and untouched scores, the grand mean of all 16 items to get the overall compassion score. Total scores will range from 1.0 to 5.0, where higher scores indicate greater overall compassion.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Compassion
Post-test
|
4.38 score on a scale
Standard Deviation 0.46
|
4.15 score on a scale
Standard Deviation 0.56
|
|
Compassion
Baseline
|
4.16 score on a scale
Standard Deviation 0.55
|
4.04 score on a scale
Standard Deviation 0.66
|
|
Compassion
3-months post intervention
|
4.18 score on a scale
Standard Deviation 0.50
|
4.27 score on a scale
Standard Deviation 0.54
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention group, 44 participants answered RSCSE questions at baseline. At the post-test, 41 participants answered the RSCSE questions. At the 3-month follow-up, 39 participants answered the RSCSE questions. In the control group, 23 participants answered RSCSE questions at baseline and post-test. At the 3-month follow-up, 20 participants answered the RSCSE questions.
The Revised Caregiver Self-efficacy (RSCSE), assessing domains of self-efficacy including obtaining respite, responding to disruptive patient behaviors and controlling upsetting through, is a 15-item inventory with scores calculated as the mean across items, with higher scores indicating greater self-efficacy. There are 3 5-item subscales: Self-Efficacy for Obtaining Respite, Self-Efficacy for Responding to Disruptive Behaviors, and Self-Efficacy for Controlling Upsetting Thoughts. Each item is rated on a scale from 0-100. The subscale score is calculated by taking the mathematical average of the items within a specific subscale (0 to 100). The total score is calculated by taking the mathematical average of the non-missing items within a specific subscale (0 to 100).
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Caregiver Self-efficacy
Baseline
|
53.39 score on a scale
Standard Deviation 17.11
|
50.18 score on a scale
Standard Deviation 19.45
|
|
Caregiver Self-efficacy
Post-test
|
55.74 score on a scale
Standard Deviation 21.34
|
62.32 score on a scale
Standard Deviation 19.07
|
|
Caregiver Self-efficacy
3-months post intervention
|
57.60 score on a scale
Standard Deviation 17.98
|
62.67 score on a scale
Standard Deviation 22.96
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention group, 45 participants answered UCLA questions at baseline. At the post-test, 41 participants answered the UCLA questions. At the 3-month follow-up, 40 participants answered the UCLA questions. In the control group, 23 participants answered RSCSE questions at baseline. At the post-test, 22 participants answered the UCLA questions. At the 3-month follow-up, 19 participants answered the UCLA questions.
The University of California, Los Angeles (UCLA) 3-item loneliness scale assesses relational connectedness, social connectedness and self-perceived isolation. The scores for each individual question can be added together to give participants a possible range of scores from 3 to 9. Researchers in the past have grouped people who score 3 - 5 as "not lonely" and people with the score 6 - 9 as "lonely".
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Loneliness
Baseline
|
6.61 score on a scale
Standard Deviation 1.56
|
7.02 score on a scale
Standard Deviation 1.86
|
|
Loneliness
Post-test
|
6.36 score on a scale
Standard Deviation 1.97
|
6.44 score on a scale
Standard Deviation 1.83
|
|
Loneliness
3-months post intervention
|
5.84 score on a scale
Standard Deviation 2.29
|
6.00 score on a scale
Standard Deviation 2.14
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention group, 45 participants answered ISEL questions at baseline. At the post-test, 41 participants answered the ISEL questions. At the 3-month follow-up, 40 participants answered the ISEL questions. In the control group, 23 participants answered ISEL questions at baseline. At the post-test, 22 participants answered the ISEL questions. At the 3-month follow-up, 19 participants answered the ISEL questions.
The Interpersonal Support Evaluation List short form (ISEL) is a 12-item measure of perceptions of social support. Each of the 12 items is rated on a 4 point Likert scale from 0-3. Items are separated into subscales as follows: Appraisal Support (Items 2, 4, 6, 11), Belonging Support (Items 1, 5, 7, 9) and Tangible Support (Items 3, 8, 10, 12). Negative items (1, 2, 7, 8, 11, 12) are reverse coded. All 12 item scores are summed together, including reverse coded and untouched items, to get a score from 0-36, with higher total scores indicating a stronger perception of available social support.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Social Support
Baseline
|
33.74 score on a scale
Standard Deviation 5.76
|
32.73 score on a scale
Standard Deviation 8.53
|
|
Social Support
Post-test
|
35.45 score on a scale
Standard Deviation 7.69
|
33.78 score on a scale
Standard Deviation 8.23
|
|
Social Support
3-months post intervention
|
35.53 score on a scale
Standard Deviation 6.93
|
34.95 score on a scale
Standard Deviation 8.49
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention group, 45 participants answered WHO-D questions at baseline. At the post-test, 42 participants answered the WHO-D questions. At the 3-month follow-up, 41 participants answered the WHO-D questions. In the control group, 23 participants answered WHO-D questions at baseline. At the post-test, 22 participants answered the WHO-D questions. At the 3-month follow-up, 21 participants answered the WHO-D questions.
The World Health Organization-Five Well-Being Index (WHO-D) has 5 items assessing emotional well-being. The raw score is calculated by totaling the figures of the five answers. The raw score ranges from 0 to 25, 0 representing worst possible and 25 representing best possible quality of life.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Well-being
3-months post intervention
|
12.33 score on a scale
Standard Deviation 6.56
|
12.76 score on a scale
Standard Deviation 6.25
|
|
Well-being
Baseline
|
11.17 score on a scale
Standard Deviation 4.10
|
8.80 score on a scale
Standard Deviation 5.18
|
|
Well-being
Post-test
|
12.78 score on a scale
Standard Deviation 5.47
|
11.48 score on a scale
Standard Deviation 6.17
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention group, 45 participants answered NPI questions at baseline. At the post-test, 42 participants answered the NPI questions. At the 3-month follow-up, 41 participants answered the NPI questions. In the control group, 23 participants answered NPI questions at baseline. At the post-test, 22 participants answered the NPI questions. At the 3-month follow-up, 20 participants answered the NPI questions.
The Neuropsychiatric Inventory (NPI) Caregiver Distress Scale has 12 items assessing distress associated with dementia patient's behaviors such as apathy, elation, disinhibition. Participant distress is rated for each positive neuropsychiatric symptom domain on a scale anchored by score from 0 to 5 points. The Score is: 0 = Not distressing at all, 1 = Minimal (slightly distressing, not a problem to cope with), 2 = Mild (not very distressing, generally easy to cope with), 3 = Moderate (fairly distressing, not always easy to cope with), 4 = Severe (very distressing, difficult to cope with), 5 = Extreme of Very Severe (extremely distressing, unable to cope with). The scores are added up for all 12 items, and the final score reported below ranges from 0-60 (a lower score indicates lower levels of stress and a better outcome).
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Distress Due to Patient Challenges Behaviors
Baseline
|
5.91 score on a scale
Standard Deviation 2.09
|
6.56 score on a scale
Standard Deviation 2.13
|
|
Distress Due to Patient Challenges Behaviors
Post-test
|
5.73 score on a scale
Standard Deviation 2.43
|
6.12 score on a scale
Standard Deviation 2.42
|
|
Distress Due to Patient Challenges Behaviors
3-months post intervention
|
5.30 score on a scale
Standard Deviation 2.68
|
4.97 score on a scale
Standard Deviation 2.57
|
OTHER_PRE_SPECIFIED outcome
Timeframe: Baseline, Post-intervention (6-8 weeks post baseline), 3-months post interventionPopulation: In the intervention group, 45 participants answered DRS questions at baseline. At the post-test, 41 participants answered the DRS questions. At the 3-month follow-up, 40 participants answered the DRS questions. In the control group, 23 participants answered DRS questions at baseline. At the post-test, 22 participants answered the DRS questions. At the 3-month follow-up, 19 participants answered the DRS questions
The Dyadic Relationship Scale (DRS) (11 items) assesses negative and positive dyadic interactions between caregivers and their care recipient. Each item is rated on four-point scale (0-3) and responses are summed for a total score. Possible scores range from 0 to 33 with higher scores indicating higher levels of strain and positive interaction.
Outcome measures
| Measure |
Control
n=23 Participants
HEP
|
Intervention
n=45 Participants
MASC
|
|---|---|---|
|
Dyadic Relationship Scale
Baseline
|
13.39 score on a scale
Standard Deviation 3.49
|
14.98 score on a scale
Standard Deviation 3.56
|
|
Dyadic Relationship Scale
Post-test
|
12.50 score on a scale
Standard Deviation 3.80
|
12.73 score on a scale
Standard Deviation 3.68
|
|
Dyadic Relationship Scale
3-months post intervention
|
12.42 score on a scale
Standard Deviation 3.67
|
12.20 score on a scale
Standard Deviation 3.28
|
Adverse Events
Mindful and Self-Compassionate Care Program (MASC)
Health Education Program (HEP)
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place